Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
about
Polymer Encapsulation of an Amorphous Pharmaceutical by initiated Chemical Vapor Deposition for Enhanced StabilityFabrication, characterization and in vitro evaluation of silibinin nanoparticles: an attempt to enhance its oral bioavailabilityInvestigation for the amorphous state of ER-34122, a dual 5-lipoxygenase/cyclooxygenase inhibitor with poor aqueous solubility, in HPMC solid dispersion prepared by the solvent evaporation method.In vitro and in vivo evaluation of amorphous solid dispersions generated by different bench-scale processes, using griseofulvin as a model compound.A novel domperidone hydrogel: preparation, characterization, pharmacokinetic, and pharmacodynamic properties.Impact of Micellar Surfactant on Supersaturation and Insight into Solubilization Mechanisms in Supersaturated Solutions of Atazanavir.Amorphous solid dispersions of sulfonamide/Soluplus® and sulfonamide/PVP prepared by ball milling.Stability of amorphous pharmaceutical solids: crystal growth mechanisms and effect of polymer additivesInorganic matrices: an answer to low drug solubility problem.Theory and practice of supersaturatable formulations for poorly soluble drugs.Influence of Copolymer Composition on In Vitro and In Vivo Performance of Celecoxib-PVP/VA Amorphous Solid Dispersions.In vitro characterization of a novel polymeric system for preparation of amorphous solid drug dispersionsClassification of the crystallization behavior of amorphous active pharmaceutical ingredients in aqueous environments.Impact of Solubilizing Additives on Supersaturation and Membrane Transport of Drugs.Evaluation of different screening methods to understand the dissolution behaviors of amorphous solid dispersions.Solubility advantage from amorphous etoricoxib solid dispersions.Using Environment-Sensitive Fluorescent Probes to Characterize Liquid-Liquid Phase Separation in Supersaturated Solutions of Poorly Water Soluble Compounds.Influence of Low-Molecular-Weight Excipients on the Phase Behavior of PVPVA64 Amorphous Solid Dispersions.Phase Behavior of Ritonavir Amorphous Solid Dispersions during Hydration and Dissolution.The Complex Solid-State Landscape of Sodium Diatrizoate Hydrates.Dual-mechanism gastroretentive drug delivery system loaded with an amorphous solid dispersion prepared by hot-melt extrusion.Introductory lecture: Mechanochemistry, a versatile synthesis strategy for new materials.Characterization of Supersaturated Danazol Solutions - Impact of Polymers on Solution Properties and Phase Transitions.Salt formation during freeze-drying--an approach to enhance indomethacin dissolution.pH-Induced precipitation behavior of weakly basic compounds: determination of extent and duration of supersaturation using potentiometric titration and correlation to solid state properties.Tailoring supersaturation from amorphous solid dispersions.Berberine nanoparticles with enhanced in vitro bioavailability: characterization and antimicrobial activity.Understanding dissolution and crystallization with imaging: a surface point of viewInsights into Nano- and Micron-Scale Phase Separation in Amorphous Solid Dispersions Using Fluorescence-Based Techniques in Combination with Solid State Nuclear Magnetic Resonance SpectroscopyInhibition of solution crystal growth of ritonavir by cellulose polymers – factors influencing polymer effectivenessQuantitative analysis of the inhibitory effect of HPMC on felodipine crystallization kinetics using population balance modelingPreparation and characterization of spray-dried co-amorphous drug-amino acid salts
P2860
Q28828863-B334058E-BFC8-484C-A3DC-D858EB2712A8Q33713924-F33FD131-2BB8-445A-9D6A-E99CC03E0D4BQ34240378-2F9C8D9E-8542-4696-B614-3334E4B9861FQ34605997-97AE84AA-DB8D-4664-843A-53DAE11D0A25Q34730346-758DC410-490C-4ED5-A681-AAC7CA8211C6Q36326329-BEAEFCB4-F66C-4576-822A-D25699073CE1Q36636489-FEC5D12A-24A9-4BEC-973F-B3BEA84B6A8AQ37995510-66FA8488-1C71-488B-AB72-7E9FA7A16CBFQ38051672-62E11238-364F-47DF-897C-94D689200F5CQ38411345-54019EA6-5F0D-4134-BB03-299EF45C5DAFQ38790753-47719932-BBCA-43B7-B6C5-64F25459E1EAQ41150354-D1EA3153-E0E6-4B7D-8C6D-9C9599311E9AQ44032375-3E74803E-3947-4D5F-9784-8E8A6F35098CQ44062316-CF429BDD-EDD9-4653-90B7-81C12A8FF22AQ44412274-F529A54A-5DA7-4D43-8E86-1B529E4D89C7Q44598171-DA80BCE6-B3C4-4C60-B28B-3B09B83B2CCDQ46049295-E8A00FCC-E9F4-4030-BC2D-39A73FE7ED1CQ47172259-F9962C99-856F-42FD-BA6F-3E3550EEB2C1Q47624194-96ADF752-821C-424E-A4AD-698176FA3926Q47837637-FE66CF49-971B-4D3D-B63B-C80481687DF9Q47838404-A205BCC5-90D6-428E-BC8A-77F1C607D957Q48520512-F4B6B01A-7D55-4488-AE5F-ACF825FB36C7Q48627689-BCAA2AF0-807B-428C-ACC1-4EF33D1A84ECQ50443082-1A5DA5D8-F4B6-472A-870F-F9F685EF5EFDQ51369136-D7A5BF7B-E395-4399-9584-FCA04A229863Q53410930-7242CC82-4150-457F-A9FF-4B9372B099D0Q54956078-1A03465B-C432-45AA-BA1A-F953F4B0D371Q57130573-F905A579-FACA-4A66-96F4-606851E0F18EQ57351454-304AF129-1D94-4C72-894C-7CE6D5AB8457Q57376538-5EC130F7-3469-4506-91EF-1DC0A15CF52EQ57376540-6811028B-C166-4542-B125-4F8407A3C78AQ59234161-9EE6B958-40D5-45E4-96B4-337FE98595FC
P2860
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@en
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@nl
type
label
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@en
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@nl
prefLabel
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@en
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@nl
P2093
P356
P1476
Solubility advantage of amorphous pharmaceuticals: I. A thermodynamic analysis.
@en
P2093
Michael J Pikal
Ravi M Shanker
Robin H Bogner
Sharad B Murdande
P304
P356
10.1002/JPS.21903
P407
P577
2010-03-01T00:00:00Z